Strong Prescription Growth and Strategic Marketing Drive Bausch + Lomb’s Positive Outlook
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...